Citizens will be able to create their ABHA (Ayushman Bharat Health Account) numbers, to which their digital health records can be linked
Keytruda plus Lenvima is also approved in the U.S. and Europe for the first-line treatment of adult patients with advanced RCC.
The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
New InterStim X system provides 10 to 15 years of battery life without the need to recharge
The sale is expected to close in the first quarter of 2022
The partnership is already underway having launched earlier last week, and the contract could be worth up to £211 million.
Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market
The brand has added a range of exciting new products especially formulated for oily skin.
With ValGenesis VLMS, change control driven validation activities are reduced from weeks to mere hours, and the company gains faster access to detailed metrics that help reduce costs and cycle time
Subscribe To Our Newsletter & Stay Updated
